Eli Lilly to acquire Centessa and drugs for sleep disorders
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive…
health care industry
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
Novo says Wegovy pill outperforms Lilly's oral GLP-1
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images The Wegovy pill showed more pronounced weight loss…
Eli Lilly Opposes Trump's MFN Drug Pricing Law, Says CEO Ricks
Dave Ricks, CEO of Eli Lilly, speaks in the Oval Office during an event on weight loss drugs at the…
Eli Lilly GLP-1 Foundayo pill approved for obesity
The US Food and Drug Administration has approved Eli LillyThe GLP-1 pill, the company said, is a major milestone for…
Novo Nordisk launches Wegovy subscription for GLP-1 anti-obesity drugs
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images Nordisk on Tuesday launched a multi-month subscription program…
Stocks Soar on Hope for Iran War Resolution; In addition, Lilly suffers a big change in sleep disorders
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Eli Lilly reaches agreement to bring AI-developed medicines to the global market
A drone view shows the Eli Lilly logo at the company's office in San Diego, California, on November 21, 2025.…
AstraZeneca shares rise after surprise lung disease trial win
AstraZenecaShares rose more than 3% after Britain's most valuable company said its experimental drug for lung diseases met its target…
Pfizer Lyme Disease Vaccine Fails in Trial, Company Will Seek FDA Approval
Thomas Fuller | Nurfoto | fake images Pfizer on Monday said it will seek regulatory approval for a Lyme disease…